Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approach
B. Ten Haaft(University of Amsterdam), Myriam Chalabi(Oncode Institute), Freek Brandts, Berthe M.P. Aleman(The Netherlands Cancer Institute), Ankie M.T. van der Velden, G. de Bruin, Janneke E. van den Bergh(Dutch Cancer Society), Marc G. Besselink(Amsterdam Neuroscience), Mark I. van Berge Henegouwen(University of Namur), Annemarieke Bartels‐Rutten(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), K. S. Boparai, Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Johanna W. van Sandick(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Sandra D. Bakker, Hanneke Beaumont, Anne-Marie van Berkel(University of Amsterdam), Wilhelmina H. Schreurs(Northwest Hospital), Caroline Wientjes(OLVG), Olivier R. Busch(Amsterdam Neuroscience), Myrte Gorris(Amsterdam University Medical Centers), Anne M. van Geel(Northwest Hospital), Joanne Verheij, Tineke E. Buffart(Amsterdam University Medical Centers), Jurriaan B. Tuynman(Amsterdam Neuroscience), Michael F. Gerhards(Erasmus MC), Djuna L. Cahen(Erasmus MC), Joris I. Erdmann(Amsterdam University Medical Centers), Chris A. Bakker, Daud Allajar(OLVG), Francine E.M. Voncken(The Netherlands Cancer Institute), Karen Bolhuis(The Netherlands Cancer Institute), Liudmila L. Kodach(The Netherlands Cancer Institute), Barbara M. Zonderhuis(Amsterdam Neuroscience), Geerard L. Beets(The Netherlands Cancer Institute), Barbara A.J. Bastiaansen, Regina G. H. Beets‐Tan(Maastricht University), Johanna W. Wilmink(Amsterdam University Medical Centers), Geert Kazemier(Cancer Center Amsterdam), Liesbeth M. Kager(Northwest Hospital), Serge E. Dohmen(Amsterdam University Medical Centers), Caroline S. Andeweg, Jan-Bart M. Koorstra(Tergooi), Annelien E. Laeijendecker(Cancer Center Amsterdam), Niels F.M. Kok(The Netherlands Cancer Institute), Dirkje W. Sommeijer, Mariska Bloedjes, Eva Versteijne(Cancer Center Amsterdam)
Cited by 1
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852